Viewing Study NCT02856451


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-01 @ 7:41 PM
Study NCT ID: NCT02856451
Status: COMPLETED
Last Update Posted: 2022-06-30
First Post: 2016-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module